SUBSCRIBERS
Shanghai Pharma buys Cardinal Health's China business for US$557m
Add BT as a preferred sourcePublished Wed, Nov 15, 2017 · 09:50 PM
Hong Kong
SHANGHAI Pharmaceuticals Holding Co has agreed to buy Cardinal Health Inc's China drug distribution business for US$557 million, winning a highly competitive auction in a move that will greatly expand its presence nationwide.
The deal will also help Shanghai Pharma, China's third largest drug distributor, become a leading importer of foreign medicine into the world's second largest drug market.
Share with us your feedback on BT's products and services
